Reference:
Front Line COVID-19 Critical Care Alliance. (2021). Prevention & early outpatient treatment protocol for COVID-19. FLCCC Alliance. https://www.flccc.net
Summary:
The FLCCC Alliance’s I-MASK+ protocol outlines a comprehensive approach to preventing and treating COVID-19, particularly for high-risk individuals. Prevention measures include administering Ivermectin at a dosage of 0.2 mg/kg, Vitamin D3, Vitamin C, Quercetin, Zinc, and Melatonin. For post-exposure, the protocol recommends similar dosages of Ivermectin with additional vitamins and monitoring of oxygen saturation. Early outpatient treatment also includes Ivermectin, Fluoxetine, and other supportive measures like nasal sprays and mouth gargles. The guidelines stress the importance of using masks, maintaining physical distance, and hand hygiene. Recommendations for pulse oximetry usage are provided to monitor oxygen levels, especially in symptomatic patients. The protocol acknowledges the need for ongoing updates based on emerging scientific research and highlights the necessity of consulting healthcare professionals before starting any treatment. It is crucial to balance the benefits and risks of medications like Ivermectin, particularly during pregnancy. The document serves as an educational resource to inform about potential therapies while emphasising the importance of professional medical advice.